BackKobayashi Pharmaceutical , Ltd. Overview

Kobayashi Pharmaceutical , Ltd. Current Assets

Kobayashi Pharmaceutical , Ltd.'s current assets is $130B.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$127.78B
↓ 4.59% YoYΔ $-6.14B vs prior year quarter

Peer trimmed avg / median

Loading

Kobayashi Pharmaceutical , Ltd. Current Assets History

Loading

Kobayashi Pharmaceutical , Ltd. vs. peers: Current Assets Comparison

Loading

Kobayashi Pharmaceutical , Ltd. Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Kobayashi Pharmaceutical , Ltd. (4967.T) FAQ

As of the most recent data (September 2026), 4967.T shows a current assets of $130B. That compares with $130B in the prior-year period — down 4.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4967.T's current assets is now $130B (was $130B) — a 4.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Kobayashi Pharmaceutical , Ltd. is outperforming or lagging.

Tracking 4967.T's current assets over time shows whether Kobayashi Pharmaceutical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $130B That compares with $130B in the prior-year period — down 4.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Kobayashi Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $130B) with ownership activity and broader fundamentals.